Impairment of vascular endothelial function following reperfusion therapy in patients with acute myocardial infarction

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 1074-1078

  Yang, Zhaoying ^a,b   Li, Jinliang ^a,b   Kong, Jian ^a   Wu, Suisheng ^a  

^a JILIN UNIVERSITY   (China)

^b HEILONGJIANG PROVINCIAL HOSPITAL   (China)

Author keywords

Acute myocardial infarction; endothelial nitric oxide synthase (eNOS); endothelin 1; nitric oxide; reperfusion therapy

Indexed keywords

CARDIOVASCULAR AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HEPARIN; NITRIC OXIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; REPERFUSION INJURY; UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 84887395422     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513487650     Document Type: Article

References (17)

1. Winckers K, Ten Cate H, Hackeng TM. The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev 2013 Apr 27; doi: pii: S0268-960X(13)00016-7. 10.1016/j.blre.2013.03.001.
2. Herlitz J,Dellborg M,et al.Epidemiology of acute myocardial infarction with the emphasis on patients who did not reach the coronary care unit and non-AMI admissions.Int J Cardiol. 2008;128:342-349.
3. Suematsu Y, Murasato Y,et al.Safety and feasibility of high-dose administration of nicorandil before reperfusion therapy in acute myocardial infarction. Cardiovasc Interv Ther 2013 Apr 27. Epub ahead of print.
4. Grybauskas P.[Role of tissue factor in atherothrombosis].Medicina (Kaunas). 2003;39:1165-1170.
5. Barrabés JA.Endothelial function in infarct-related arteries: does the type of reperfusion therapy matter?.Rev Esp Cardiol. 2008;61:797-799.
6. Rossi GP,Maiolino G,Zanchetta M,et al.The T(-786)C endothelial nitric oxide synthase genotype pedicts cardiovascular mortality in high-risk patients.J Am Coll Cardiol. 2006;48:1166-1174.
7. Wang H and Eitzman DT. Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis 2013 Apr 12; doi: 10.1016/j.atherosclerosis.2013.04.004.
8. Li J-L,Yang Z,Wu S,et al.Relationship between endothelial nitric oxide synthase, insulin resistance and macrovascular disease in patients with acute myocardial infarction.J Int Med Res. 2012;40:687-693.
9. Antoniades C,Shirodaria C,Crabtree M,et al.Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation.Circulation. 2007;116:2851-2859.
10. Casas JP,Cavalleri GL,Bautista LE,et al.Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review.Am J Epidemiol. 2006;164:921-935.
11. Thygesen K,Alpert JS,White HD,et al.Universal definition of myocardial infarction.J Am Coll Cardiol. 2007;50:2173-2195.
12. WMA. Declaration of Helsinki, http://www.wma.net/en/20activities/10ethics/10helsinki/2008 (Accessed 08 May 2013).
13. D'Errigo P,Seccareccia F,Barone AP,et al.Effectiveness of invasive reperfusion therapy and standard medical treatment in AMI.Acta Cardiol. 2010;65:645-652.
14. Akamatsu D,Sato A,Goto H,et al.Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease.J Atheroscler Thromb. 2010;17:1266-1274.
15. Hardie KL,Kinlay S,Hardy DB,et al.Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial function.Aust N Z J Med. 1997;27:649-652.
16. Mao M,Sudhahar V,Ansenberger-Fricano K,et al.Nitroglycerin drives endothelial nitric oxide synthase activation via the phosphatidylinositol 3-kinase/protein kinase B pathway.Free Radic Biol Med. 2012;52:427-435.
17. Carlucci F,Tabucchi A,Biagioli B,et al.Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia-reperfusion.Biomed Pharmacother. 2002;56:483-491.